Vistagen Therapeutics Inc (VTGN)
2.58
+0.05
(+1.98%)
USD |
NASDAQ |
Nov 22, 16:00
2.565
-0.02
(-0.58%)
After-Hours: 20:00
Vistagen Therapeutics Revenue (Quarterly): 0.183M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.183M |
| June 30, 2024 | 0.084M |
| March 31, 2024 | 0.1973M |
| December 31, 2023 | 0.4114M |
| September 30, 2023 | 0.278M |
| June 30, 2023 | 0.177M |
| March 31, 2023 | 0.1759M |
| December 31, 2022 | 0.1796M |
| September 30, 2022 | -0.8925M |
| June 30, 2022 | 0.3101M |
| March 31, 2022 | 0.0389M |
| December 31, 2021 | 0.3579M |
| September 30, 2021 | 0.358M |
| June 30, 2021 | 0.3541M |
| March 31, 2021 | 0.4419M |
| December 31, 2020 | 0.3136M |
| September 30, 2020 | 0.334M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 1.25M |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | 0.2004M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.8925M
Minimum
Sep 2022
0.4419M
Maximum
Mar 2021
0.1942M
Average
0.278M
Median
Sep 2023
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.96M |
| Total Expenses (Quarterly) | 14.41M |
| EPS Diluted (Quarterly) | -0.42 |
| Enterprise Value | -25.74M |
| Profit Margin (Quarterly) | -7.08K% |
| Earnings Yield | -52.03% |
| Normalized Earnings Yield | -52.03 |